The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) successfully completed a Phase 1 clinical trial in Brazil of Na-GST-1/Alhydrogel®, a vaccine candidate for human...
The Sabin Vaccine Institute Product Development Partnership recently announced the launch of a vaccine discovery program for soil-transmitted helminth meant to develop candidates for stopping roundworm and whipworm...
The Sabin Vaccine Institute announced the launch of the newly-formed International Association of Immunization Managers (IAIM). With the support of a five-year grant from the Bill & Melinda Gates Foundation...